{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "11063924",
  "DateCompleted": {
    "Year": "2001",
    "Month": "01",
    "Day": "04"
  },
  "DateRevised": {
    "Year": "2015",
    "Month": "03",
    "Day": "11"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0893-133X",
      "JournalIssue": {
        "Volume": "23",
        "Issue": "6",
        "PubDate": {
          "Year": "2000",
          "Month": "Dec"
        }
      },
      "Title": "Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology",
      "ISOAbbreviation": "Neuropsychopharmacology"
    },
    "ArticleTitle": "Treatment response in depressed patients with enhanced Ca mobilization stimulated by serotonin.",
    "Pagination": {
      "StartPage": "690",
      "EndPage": "696",
      "MedlinePgn": "690-6"
    },
    "Abstract": {
      "AbstractText": [
        "Serotonin (5-HT)-stimulated intraplatelet calcium (Ca) mobilization has been shown to be enhanced in nonmedicated depressive patients by many studies. However, there has not been any longitudinal follow-up study of this parameter. We examined the relationship between treatment response and pretreatment value of the 5-HT-induced Ca response. The 5-HT(10 microM)-induced intraplatelet Ca mobilization was measured in 98 nonmedicated depressive patients (24 bipolar disorders, 51 melancholic major depressive disorders, and 23 non-melancholic major depressive disorders). These patients were followed up prospectively for a further period of five years. The depressed patients with enhanced Ca response to 5-HT in bipolar disorders exhibited a good response to mood stabilizers but those with major depressive disorders showed a poor response to antidepressants. These findings suggest the possibility that the 5-HT-induced intraplatelet Ca response may be a good predictor of treatment response in depressed patients. Longer longitudinal follow-up studies are needed in larger samples to examine if this parameter may be a specific biological marker for unipolar-bipolar dichotomy."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Psychiatry, Hokkaido University School of Medicine,., Sapporo, Japan."
          }
        ],
        "LastName": "Kusumi",
        "ForeName": "I",
        "Initials": "I"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Suzuki",
        "ForeName": "K",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Sasaki",
        "ForeName": "Y",
        "Initials": "Y"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Kameda",
        "ForeName": "K",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Koyama",
        "ForeName": "T",
        "Initials": "T"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Neuropsychopharmacology",
    "NlmUniqueID": "8904907",
    "ISSNLinking": "0893-133X"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antidepressive Agents"
    },
    {
      "RegistryNumber": "333DO1RDJY",
      "NameOfSubstance": "Serotonin"
    },
    {
      "RegistryNumber": "SY7Q814VUP",
      "NameOfSubstance": "Calcium"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Age Factors"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Antidepressive Agents"
    },
    {
      "QualifierName": [
        "blood",
        "drug therapy",
        "physiopathology"
      ],
      "DescriptorName": "Bipolar Disorder"
    },
    {
      "QualifierName": [
        "drug effects",
        "metabolism"
      ],
      "DescriptorName": "Blood Platelets"
    },
    {
      "QualifierName": [
        "blood"
      ],
      "DescriptorName": "Calcium"
    },
    {
      "QualifierName": [
        "blood",
        "drug therapy",
        "physiopathology"
      ],
      "DescriptorName": "Depression"
    },
    {
      "QualifierName": [
        "blood",
        "drug therapy",
        "physiopathology"
      ],
      "DescriptorName": "Depressive Disorder, Major"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "metabolism",
        "pharmacology"
      ],
      "DescriptorName": "Serotonin"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Sex Factors"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Treatment Outcome"
    }
  ]
}